Cannabis News

The Company's patented technology expected to be key to commercial success in cannabinoid biosynthesis

NASDAQ | TSX: ACB

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the launch of a dedicated Science & Innovation business group, with the aim of commercializing patented and patent pending technology that the Company believes will be key in the development of cannabinoid biosynthesis and plant genetics.

Aurora Cannabis Inc. Logo (CNW Group/Aurora Cannabis Inc.)

Aurora's connection to the biosynthetic production of cannabinoids originated with early work carried out by the Company's former Chief Science Officer on the discovery of key genes within the cannabinoid biosynthesis pathway. Through licensing agreements, Aurora and sub-licensee 22nd Century Group together share the global IP rights to commercialize key aspects of cannabinoid biosynthesis in plants and microorganisms. The two companies are working closely to enforce their IP against infringing parties, as well as to actively explore commercial development opportunities.

"As global cannabis regulations evolve, we believe cannabinoid molecules, including minor cannabinoids, will be incredibly important. Today, Aurora's Reliva business in the U.S. sells products that use CBD isolate, and we are deeply interested in the evolution of other cannabinoids and the ability to commercialize them," says Miguel Martin , CEO of Aurora Cannabis.  "This technology promises to be very valuable, as it potentially unlocks a more efficient means to produce cannabinoids at scale, particularly minor cannabinoids which typically occur in the plant at very low levels, less than 1%. We've created a separate Science & Innovation business to capitalize on the tremendous potential we see in this emerging space."

Currently, the Company is exploring ways to optimize the cannabinoid biosynthesis pathway within the plant itself using its IP.  Aurora and 22 nd Century Group intend to leverage Aurora's best-in-class research facility, Aurora Coast in British Columbia , where advanced breeding and genetics technologies, coupled with sensory and consumer research, are used to create new and differentiated cultivars for consumers and patients. The research facility screens thousands of unique cultivars every year to deliver a handful of elite candidates. New cultivars from its breeding program are currently with leading licenced producers, both large scale and craft, for trials and production.

"At Aurora, innovation is integral to every aspect of our company," said Charles Pick , Senior Vice President of Science & Innovation at Aurora Cannabis. "With the formalization of a Science & Innovation business unit, we anticipate being in a position to quickly bring a wide array of products to the market, to meet the diverse consumer and patient needs we are seeing globally."

About Aurora

Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in Edmonton, Alberta , Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The Company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and Reliva CBD. Providing customers with innovative, high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched. For more information, please visit our website at www.auroramj.com .

Aurora's common shares trade on the TSX and NASDAQ under the symbol "ACB" and is a constituent of the S&P/TSX Composite Index.

Cision View original content to download multimedia: http://www.prnewswire.com/news-releases/new-science--innovation-business-unit-to-advance-auroras-leadership-in-biosynthesis-and-plant-genetics-301300610.html

SOURCE Aurora Cannabis Inc.

News Provided by PR Newswire via QuoteMedia

person leaving office with box of belongings

Cannabis Weekly Round-Up: Aurora Confirms More Staff Cuts

Leading Canadian cannabis producer Aurora Cannabis (NASDAQ:ACB,TSX:ACB) confirmed it plans to let go of an undisclosed number of workers as part of its cost-cutting measures.

Meanwhile, another cannabis producer announced a purchase plan for assets belonging to a fellow producer that is currently struggling. Keep reading to find out more cannabis highlights from the past five days.

Keep reading...Show less

Centurion Announces Update on Cannabis Spinout Transaction, Share Consolidation, and Change of Transfer Agent

Centurion Minerals Ltd. (TSXV: CTN) (the "Company") is pleased to update shareholders on progress regarding previously announced plans that include:

  • distributing shares to its shareholders in a wholly owned subsidiary ("SpinCo") created to complete the previously announced, "HAI Beverage/CannaEden Group" cannabis transaction; and,

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Cronos Group Inc. Announces Results of 2022 Annual Meeting of Shareholders

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") announces that at its Annual Meeting of Shareholders held on June 23, 2022 (the "Meeting") shareholders voting in person or by proxy held in total 265,763,587 common shares of the Company, representing 70.76% of the total number of common shares of the Company outstanding.

Each of the directors listed as a nominee in the Company's proxy statement dated April 29, 2022 (the "Proxy Statement") was elected as a director of the Company, with each director receiving in excess of 91.6% of the votes cast in favor of his or her election. The detailed results of the vote for the election of directors are as follows:

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Khalifa Kush Takes Michigan Higher

TerrAscend introduces Wiz Khalifa's flower in Gage dispensaries starting June 25 th

TerrAscend Corp. ("TerrAscend" or the "Company") (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced the launch of Khalifa Kush ("KK"), a premium cannabis brand founded by Grammy ® Award-nominated recording artist Wiz Khalifa at Gage Cannabis dispensaries in Michigan starting Saturday, June 25th .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Avicanna Sells Stake in Majority-Owned Colombian Subsidiary Sativa Nativa

Avicanna Sells Stake in Majority-Owned Colombian Subsidiary Sativa Nativa

Avicanna Inc. (" Avicanna " or the " Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce the sale of its stake in Sativa Nativa S.A.S. ( "Sativa Nativa" ), which was the Company's secondary majority owned Colombian subsidiary.

The aggregate price paid by the purchaser for the Company´s shares in Sativa Nativa was approximately CAD $675,000 in addition to a potential premium of CAD $130,000 subject to the accomplishment of specific short-term milestones. The transaction allows the Company to eliminate redundancies, reduce its operational costs and generate efficiencies across its South American operations by focusing its supply chain efforts at its much larger and more operationally advanced majority owned subsidiary Santa Marta Golden Hemp ("SMGH"). The operations at SMGH have been the source of the company's Aureus-branded commercial exports to 16 countries and include the cultivation, extraction and production of cannabinoid raw materials including active pharmaceutical ingredients and seeds. SMGH is also the source of the Company's cannabinoids for most of its cosmetic and pharmaceutical preparations.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Goodness Growth Holdings Launches HiColor Cannabis Chews in New York

HiColor™ Cannabis-infused chews are now available in five flavors

Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a physician-led, science-focused cannabis company and IP developer, today announced the launch of HiColor™ cannabis-infused chews in New York which are now available through the Company's retail and wholesale channels in the New York market. The new line of cannabis-infused edibles is now available in five gourmet flavors and two formulations.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×